Facebook
X
LinkedIn
Forward
Statistics in Oncology Clinical Trials v1
Course InformationIn this course, Anastasia Ivanova, PhD, and Allison Deal, MS, will introduce key statistical concepts in oncology clinical trials. Topics will include Phase I and Phase II trial design, prognostic and predictive biomarkers, and the basics of statistical analysis methods used in oncology research. Participants will gain foundational knowledge in these areas to support understanding of clinical trial methodology. Learning Objectives
|
Course RegistrationPlease contact us with any questions at [email protected] or (919) 445–1000. DisclaimerThe views expressed herein are those of the presenter, they do not necessarily reflect the views of the contracted organization, department, School of Medicine, nor the University of North Carolina at Chapel Hill. |
 | Oncology Clinical Trials Series The Oncology Clinical Trials series, developed by Claire Dees, MD, ScM, provides an introduction to clinical research in oncology, with a focus on the design and conduct of clinical trials. Topics include trial design, implementation, regulatory and ethical considerations, data management, and common challenges in oncology research. The series also introduces complementary areas such as biomarkers, correlative studies, and other approaches that support therapeutic trials, along with considerations for career development in clinical research. This series is designed for fellows, faculty, and oncology advanced practice providers (APPs) across cancer-related disciplines, including medical, hematologic, gynecologic, urologic, head and neck, pediatric, surgical, and radiation oncology. |
 | Anastasia Ivanova, PhD Professor |
 | Allison Deal, MS Senior Biostatistician |
Available Credit
- 1.00 Participation